Ivar Aursnes

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi Common adverse events associated with an SSRI: meta-analysis of early paroxetine data
    Ivar Aursnes
    Department of Pharmacology, University of Oslo, Oslo, Norway
    Pharmacoepidemiol Drug Saf 17:707-13. 2008
  2. ncbi Suicide attempts in clinical trials with paroxetine randomised against placebo
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    BMC Med 3:14. 2005
  3. ncbi Does atenolol differ from other beta-adrenergic blockers?
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, 0316 Blindern, Oslo, Norway
    BMC Clin Pharmacol 7:4. 2007
  4. ncbi [Probability and risk]
    Ivar Aursnes
    Institutt for farmakoterapi, Universitetet i Oslo
    Tidsskr Nor Laegeforen 126:3282. 2006
  5. ncbi Even more suicide attempts in clinical trials with paroxetine randomised against placebo
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    BMC Psychiatry 6:55. 2006
  6. ncbi Clinical efficacies of antihypertensive drugs
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, Norway
    Scand Cardiovasc J 37:72-9. 2003
  7. ncbi Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortality
    Knud Landmark
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    Blood Press 12:40-5. 2003
  8. ncbi Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function
    Aasmund Reikvam
    Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, Norway
    Scand Cardiovasc J 37:130-4. 2003
  9. ncbi A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo
    Marianne Klemp
    Department of Pharmacology, University of Oslo, Oslo, Norway
    J Clin Psychopharmacol 31:698-704. 2011
  10. ncbi [Do calcium antagonists prevent heart failure in hypertension?]
    Ivar Aursnes
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 124:42-3. 2004

Detail Information

Publications19

  1. ncbi Common adverse events associated with an SSRI: meta-analysis of early paroxetine data
    Ivar Aursnes
    Department of Pharmacology, University of Oslo, Oslo, Norway
    Pharmacoepidemiol Drug Saf 17:707-13. 2008
    ..We wanted to determine to what extent adverse drug effects associated with a selective serotonin reuptake inhibitor (SSRI) were known but not assessed before application for registration of paroxetine...
  2. ncbi Suicide attempts in clinical trials with paroxetine randomised against placebo
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    BMC Med 3:14. 2005
    ..Recent meta-analyses of studies on adults have indicated similar effects. We obtained unpublished data for paroxetine that have so far not been included in these analyses...
  3. ncbi Does atenolol differ from other beta-adrenergic blockers?
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, 0316 Blindern, Oslo, Norway
    BMC Clin Pharmacol 7:4. 2007
    ..These findings were not, however, statistically significant...
  4. ncbi [Probability and risk]
    Ivar Aursnes
    Institutt for farmakoterapi, Universitetet i Oslo
    Tidsskr Nor Laegeforen 126:3282. 2006
  5. ncbi Even more suicide attempts in clinical trials with paroxetine randomised against placebo
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    BMC Psychiatry 6:55. 2006
    ..Following our previous publication we have received critical comments to our conclusions as well as new data that are strengthening our findings...
  6. ncbi Clinical efficacies of antihypertensive drugs
    Ivar Aursnes
    Department of Pharmacotherapeutics, University of Oslo, Norway
    Scand Cardiovasc J 37:72-9. 2003
    ..We therefore explored the possibility of drawing statistically valid conclusions about the differences in clinical efficacy between various drug groups by doing an overview of published data...
  7. ncbi Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortality
    Knud Landmark
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    Blood Press 12:40-5. 2003
    ....
  8. ncbi Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function
    Aasmund Reikvam
    Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, Norway
    Scand Cardiovasc J 37:130-4. 2003
    ....
  9. ncbi A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo
    Marianne Klemp
    Department of Pharmacology, University of Oslo, Oslo, Norway
    J Clin Psychopharmacol 31:698-704. 2011
    ....
  10. ncbi [Do calcium antagonists prevent heart failure in hypertension?]
    Ivar Aursnes
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 124:42-3. 2004
  11. ncbi [Omega-3-fatty acids still beneficial in cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, 0316 Oslo
    Tidsskr Nor Laegeforen 127:202-3. 2007
  12. ncbi Meta-regression analysis of paroxetine clinical trial data: does reporting scale matter?
    Marianne Klemp
    Department of Pharmacology, University of Oslo, Oslo, Norway
    J Clin Psychopharmacol 31:201-6. 2011
    ..It is unknown to which degree the effect of antidepressant drugs are related to baseline degree of depression, dose level, patient's age, or type of questionnaire used. We explored this for paroxetine...
  13. ncbi Deficient supplies of drugs for life threatening diseases in an African community
    Norman N Lufesi
    Department of General Practice and Community Medicine Section for International Health, University of Oslo, Oslo, Norway
    BMC Health Serv Res 7:86. 2007
    ....
  14. ncbi Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapy
    Asmund Reikvam
    Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, N 0316 Oslo, Norway
    Cardiovasc Drugs Ther 16:451-6. 2002
    ....
  15. ncbi [Attitudes to estrogen replacement therapy among Norwegian women]
    Anne Cecilie Hallquist
    Institutt for farmakoterapi, Universitetet i Oslo, 0316 Oslo
    Tidsskr Nor Laegeforen 126:1195-7. 2006
    ..The aim of the study was to investigate women's attitudes towards hormone treatment (HT), their judgment of the various sources of information, and their knowledge of indications for HT...
  16. ncbi [Anticholesteremic agents and omega-3 fatty acids]
    Knud Landmark
    Tidsskr Nor Laegeforen 123:212; author reply 212. 2003
  17. ncbi [Thiazides or ACE inhibitors? A drug-economic analysis]
    Ivar Aursnes
    Tidsskr Nor Laegeforen 124:1668. 2004
  18. ncbi [Mercury, fish, fish oil and the risk of cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 124:198-200. 2004
    ..One possible explanation for this paradox could be a high content of mercury in fish...
  19. ncbi [Bayesian thinking on its way into medical statistics?]
    Ivar Aursnes
    Institutt for farmakoterapi Postboks 1065 Blindern
    Tidsskr Nor Laegeforen 122:1369-72. 2002
    ..Bayesian statistical analysis is a paradigm quite different from traditional statistical inference. We wanted to show the usefulness of this approach for some medical problems...